Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R S Negrin

Showing results (51-60 of 99) with videos related to

Pageof 10
Sort By:
Experimental Hematology|August 1, 1995
Enrichment of bone marrow and blood progenitor (CD34+) cells by density gradients with sufficient yields for transplantationJ R Schriber, S Dejbakhsh-Jones, C R Kusnierz-Glaz, et al.
Clinical Transplants|January 1, 1990
Bone marrow transplantation for hematologic malignancies: the Stanford experienceN J Chao, M D Amylon, G D Long, et al.
Lancet (London, England)|June 6, 1992
G-CSF and peripheral blood progenitor cellsN J Chao, G D Long, R S Negrin, et al.
International Journal of Cancer|December 18, 2001
Hodgkin disease-derived cell lines expressing ubiquitous mitochondrial creatine kinase show growth inhibition by cyclocreatine treatment independent of apoptosisM Kornacker, U Schlattner, T Wallimann, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 24, 2001
CD31 mismatching affects marrow transplantation outcomeF C Grumet, D D Hiraki, Brown BWM, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 1999
A feasibility study of multiple cycle therapy with melphalan, thiotepa, and paclitaxel followed by mitoxantrone, thiotepa, and paclitaxel with autologous hematopoietic cell support for metastatic breast cancerW W Hu, G D Long, K E Stockerl-Goldstein, et al.
Blood|June 25, 1999
Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantationL Ruggeri, M Capanni, M Casucci, et al.
Cancer|September 1, 1995
Multiple cycles of high dose chemotherapy supported by hematopoietic progenitor cells as treatment for patients with advanced malignanciesG D Long, R S Negrin, C F Hoyle, et al.
Cellular Immunology|April 10, 1996
Sensitivity of multidrug-resistant tumor cell lines to immunologic effector cellsI G Schmidt-Wolf, P Lefterova, V Johnston, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 16, 1999
Visualizing the kinetics of tumor-cell clearance in living animalsT J Sweeney, V Mailänder, A A Tucker, et al.
Pageof 10

Showing results (51-60 of 99) with videos related to

Sort By:
Pageof 10
Experimental Hematology|August 1, 1995
Enrichment of bone marrow and blood progenitor (CD34+) cells by density gradients with sufficient yields for transplantationJ R Schriber, S Dejbakhsh-Jones, C R Kusnierz-Glaz, et al.
Clinical Transplants|January 1, 1990
Bone marrow transplantation for hematologic malignancies: the Stanford experienceN J Chao, M D Amylon, G D Long, et al.
Lancet (London, England)|June 6, 1992
G-CSF and peripheral blood progenitor cellsN J Chao, G D Long, R S Negrin, et al.
International Journal of Cancer|December 18, 2001
Hodgkin disease-derived cell lines expressing ubiquitous mitochondrial creatine kinase show growth inhibition by cyclocreatine treatment independent of apoptosisM Kornacker, U Schlattner, T Wallimann, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 24, 2001
CD31 mismatching affects marrow transplantation outcomeF C Grumet, D D Hiraki, Brown BWM, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 1999
A feasibility study of multiple cycle therapy with melphalan, thiotepa, and paclitaxel followed by mitoxantrone, thiotepa, and paclitaxel with autologous hematopoietic cell support for metastatic breast cancerW W Hu, G D Long, K E Stockerl-Goldstein, et al.
Blood|June 25, 1999
Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantationL Ruggeri, M Capanni, M Casucci, et al.
Cancer|September 1, 1995
Multiple cycles of high dose chemotherapy supported by hematopoietic progenitor cells as treatment for patients with advanced malignanciesG D Long, R S Negrin, C F Hoyle, et al.
Cellular Immunology|April 10, 1996
Sensitivity of multidrug-resistant tumor cell lines to immunologic effector cellsI G Schmidt-Wolf, P Lefterova, V Johnston, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 16, 1999
Visualizing the kinetics of tumor-cell clearance in living animalsT J Sweeney, V Mailänder, A A Tucker, et al.
Pageof 10